[CHRS] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
08-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- 1.51%
YoY- -14.36%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 116,180 37,098 0 161 12,359 5,810 3,596 78.37%
PBT 36,505 -20,004 -44,302 -74,822 -65,538 -40,839 -25,170 -
Tax 933 5,027 2,541 2,303 338 -4,205 -5,927 -
NP 35,572 -20,004 -44,297 -74,778 -65,388 -40,725 -25,170 -
Tax Rate -2.56% - - - - - - -
Total Cost 80,608 57,102 44,297 74,939 77,747 46,535 28,766 18.71%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 30.62 -53.92 0.00 -46,445.96 -529.07 -700.95 -699.94 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS 0.50 -0.29 -0.74 -1.54 -1.67 -1.22 -1.39 -
EPS Diluted 0.48 -0.29 -0.74 -1.54 -1.67 -1.22 -1.39 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.